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As of June 1, 2020, coronavirus disease 2019 (COVID-19) has caused more than
6,000,000 infected persons and 360,000 deaths globally. Previous studies revealed preg-
nant women with COVID-19 had similar clinical manifestations to nonpregnant women.
However, little is known about the outcome of neonates born to infected women.
Methods and findings
In this retrospective study, we studied 29 pregnant women with COVID-19 infection deliv-
ered in 2 designated general hospitals in Wuhan, China between January 30 and March
10, 2020, and 30 neonates (1 set of twins). Maternal demographic characteristics, delivery
course, symptoms, and laboratory tests from hospital records were extracted. Neonates
were hospitalized if they had symptoms (5 cases) or their guardians agreed to a hospitalized
quarantine (13 cases), whereas symptom-free neonates also could be discharged after birth
and followed up through telephone (12 cases). For hospitalized neonates, laboratory test
results and chest X-ray or computed tomography (CT) were extracted from hospital records.
The presence of antibody of SARS-CoV-2 was assessed in the serum of 4 neonates.
Among 29 pregnant COVID-19-infected women (13 confirmed and 16 clinical diag-
nosed), the majority had higher education (56.6%), half were employed (51.7%), and their
mean age was 29 years. Fourteen women experienced mild symptoms including fever (8),
cough (9), shortness of breath (3), diarrhea (2), vomiting (1), and 15 were symptom-free.
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Eleven of 29 women had pregnancy complications, and 27 elected to have a cesarean sec-
tion delivery.
Of 30 neonates, 18 were admitted to Wuhan Children’s Hospital for quarantine and care,
whereas the other 12 neonates discharged after birth without any symptoms and had normal
follow-up. Five hospitalized neonates were diagnosed as COVID-19 infection (2 confirmed
and 3 suspected). In addition, 12 of 13 other hospitalized neonates presented with radiologi-
cal features for pneumonia through X-ray or CT screening, 1 with occasional cough and the
others without associated symptoms. SARS-CoV-2 specific serum immunoglobulin M (IgM)
and immunoglobulin G (IgG) were measured in 4 neonates and 2 were positive. The limited
sample size limited statistical comparison between groups.
Conclusions
In this study, we observed COVID-19 or radiological features of pneumonia in some, but
not all, neonates born to women with COVID-19 infection. These findings suggest that
intrauterine or intrapartum transmission is possible and warrants clinical caution and further
investigation.
Trial registration
Chinese Clinical Trial Registry, ChiCTR2000031954 (Maternal and Perinatal Outcomes
of Women with coronavirus disease 2019 (COVID-19): a multicenter retrospective cohort
study).
Author summary
Why was this study done?
• Previous studies suggest COVID-19 infections in pregnant women are not more severe
than in women of similar age.
• However, little is known about the outcome of neonates born to COVID-19-infected
women.
What did the researchers do and find?
• We analyzed the clinical features of all pregnant women with COVID-19 infection
delivered in 2 of the 5 designated general hospitals in Wuhan, China between January
30 and March 10, 2020, and their neonates.
• Among the 30 neonates born to 29 pregnant COVID-19-infected women (1 set of
twins), 5 were diagnosed as having COVID-19 (2 confirmed and 3 suspected), and the
other 12 neonates presented radiological features of pneumonia, but none were diag-
nosed with pneumonia.
• Three neonates developed necrotizing enterocolitis, although none of them were
premature.
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What do these findings mean?
• A considerable number of, but not all, neonates born to COVID-19-infected women
developed COVID-19 (5/30) or had pneumonia-like radiological features (17/30).
• Intrapartum precaution should not be underestimated, and intrauterine transmission
should be considered based on current evidence.
• Term neonates born to COVID-19-infected women are vulnerable to develop necrotiz-
ing enterocolitis.
Introduction
Since December 2019, a novel coronavirus called severe acute respiratory syndrome corona-
virus 2 (SARS-CoV-2) has spread through human-to-human transmission across China [1]
and now internationally to over 160 countries. The World Health Organization initially clas-
sified the outbreak of the coronavirus disease 2019 (COVID-19) as a Public Health Emer-
gency of International Concern (PHEIC), and on March 11, 2020, they upgraded it to a
pandemic [2]. According to the Chinese Center for Disease Control and Prevention (China
CDC), 25.1% of the 44,672 confirmed cases in mainland China were women of reproductive
age [3,4]. Pregnant women experience immunologic and physiologic changes, which make
them potentially more susceptible to viral respiratory infections, including respiratory syncy-
tial virus, influenza virus, and SARS-CoV [5]. There is growing evidence that COVID-19
infections in pregnant women are not more severe than in age-matched women where symp-
toms are typically mild [6–12], and childbirth did not aggravate the course of the illness or
chest computed tomography (CT) features of COVID-19 [13]. In addition, previous research
suggests infants under 1 year old are susceptible to COVID-19 when in contact with infected
family members [14]. However, for neonates born to infected women, little is known about
their susceptibility.
In this retrospective study, we analyzed maternal and neonatal clinical characteristics of all
women with confirmed or clinical diagnosed COVID-19 infection who gave birth in 2 of the 5
general hospitals in Wuhan, China and followed up their neonates through telephone inter-
view or collecting their clinical data in the only designated children’s hospital to assess neona-
tal outcomes associated with maternal COVID-19 infection.
Methods
Study design and participants
All pregnant women diagnosed with COVID-19 who gave birth between January 30 to March
10, 2020 in 2 designated general hospitals in Wuhan, China (Renmin Hospital, Wuhan Uni-
versity, and Central Hospital of Wuhan, Tongji Medical College, Huazhong University of
Science and Technology) were included in this retrospective study. Clinical characteristics,
examination results, and treatment course were extracted from their medical records.
All procedures performed in this study involving human participants were in accordance
with the ethical standards of the Medical Ethical Committee of Wuhan Children’s Hospital
(Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong Univer-
sity of Science and Technology (WHCH2020014), Central Hospital of Wuhan, Tongji Medical
College, Huazhong University of Science and Technology (2020–28), and Renmin Hospital,
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Wuhan University (WDRY2020-K097). For this retrospective study in clinical practice, the
requirement for written informed consent was waived by the ethics committee.
Maternal data
We followed the diagnostic criteria for COVID-19 in pregnant women according to the New
Coronavirus Pneumonia Prevention and Control Program (fifth, sixth, and seventh edition)
[15–17] published by the National Health Commission of China (specific diagnostic criteria
were shown in S1 Text). In women where a PCR-kit for SARS-CoV-2 RNA was not available,
the diagnosis was made with chest CT scan.
For mothers, we collected sociodemographic data (maternal age, body mass index [BMI],
educational attainment [>high school or not], and occupation [employed specifically at a hos-
pital, employed but not at a hospital, or unemployed]), maternal parity (primiparous or mul-
tiparous), medical history records (fever, cough, shortness of breath, diarrhea, and vomiting),
laboratory tests, chest CT images, throat swab tests, use of mechanical ventilation, and inten-
sive care unit [ICU] admission. Laboratory tests included routine antenatal blood tests (white
blood cell count [WBC], lymphocyte count [LYM], lymphocyte percentage [LYM%]), levels
of C-reactive protein (CRP) in serum, biochemical indicators of hepatic and renal function
(aspartate transaminase [AST], alanine aminotransferase [ALT], creatine kinase [CK], lactate
dehydrogenase [LDH], total protein [TP], albumin [ALB], uric acid [UA], creatinine [CREA],
and urea nitrogen [BUN]), and postnatal blood routine tests and levels of CRP. For all women,
we registered pregnancy outcomes, i.e., gestational age at delivery, mode of delivery, and
occurrence of gestational hypertensive disorder, gestational diabetes mellitus, premature rup-
ture of membranes, and fetal distress.
Neonatal data
Neonates who need hospital care or who were admitted on parental request for quarantined
observation were admitted to a designated children’s hospital (Wuhan Children’s Hospital
[Wuhan Maternal and Child Healthcare Hospital], Tongji Medical College, Huazhong Univer-
sity of Science and Technology). When parents did not opt for quarantined observation, neo-
nates were discharged after birth. For these neonates, the outcome was obtained through
parental telephone interview.
Neonatal data collected included sex, birthweight, 1- and 5-minute Apgar scores, congenital
anomalies, fever, respiratory distress and neonatal ICU (NICU) admission. Neonates admitted
at NICU care had additional data collected including throat swabs, anal swabs, as well as chest
X-rays or CT images. Laboratory data collected included routine blood tests (WBC, LYM,
LYM%, neutrophil count [NEU], neutrophil percentage [NEU%], platelet count [PLT]), levels
of CRP, procalcitonin (PCT) in serum, and biochemical indicators of hepatic and renal func-
tion (AST, ALT, CK, LDH, TP, ALB, UA, CREA, and BUN). In addition, according to the
New Coronavirus Pneumonia Prevention and Control Program (seventh edition) [17], SARS-
CoV-2 specific immunoglobulin M (IgM) and immunoglobulin G (IgG) was examined in 4
neonates’ serum. The diagnosis of pneumonia in neonates was based on risk factors, clinical
manifestations, radiological findings, and laboratory tests [18]. The diagnosis of COVID-19 in
neonates was according to an experts0 consensus statement [19] (specific diagnostic criteria
are shown in S1 Text).
SARS-CoV-2 testing
Maternal and neonatal throat swabs and neonatal anal swabs were collected and tested for
SARS-CoV-2 RNA using quantitative real time-PCR (qRT-PCR) technology and hydrolysis
PLOS MEDICINE Neonates born to COVID-19 mothers
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003195 July 28, 2020 4 / 19
probe technology (the New Coronavirus 2019 Nucleic Acid Detection Kit [Dual Fluorescence
PCR] provided by Shuo Shi Biotechnology Co., Ltd, Jiangsu, China). SARS-CoV-2 specific
IgM and IgG were detected using New Coronavirus 2019-nCoV IgG Antibody Detection
Kit (Chemiluminescence) (Yahuilong Biological Technology Co., Ltd. Shenzhen, China) [20–
22]. Sample collection, processing, and laboratory testing followed guidance from the World
Health Organization [23].
Statistical analysis
All analyses were performed using SAS 9.3 (SAS Institute, Inc, North Carolina, USA, https://
www.sas.com/zh_cn/software/university-edition/download-software.html#windows). Contin-
uous variables were described as mean (standard deviation [SD]) or median (interquartile
range [IQR]). Categorical variables were represented as frequencies with proportions. All the
research data were available at the ResMen Manager of Chinese Clinical Trial Registry (www.
medresman.org), and the registration number is ChiCTR2000031954.
Results
The flow chart of the study participants was shown in Fig 1. We studied 29 women with a
COVID-19 infection, of which 13 were diagnosed with a SARS-CoV-2 RNA test using
qRT-PCR on samples from the respiratory tract, and 16 were clinically diagnosed based on
Fig 1. Flow chart of participants inclusion. Of the 30 neonates born (including 1 set of twins), 18 were admitted to the Children’s Hospital to have
further examination (5 with symptoms and 13 just for quarantine). The other 12 neonates discharged immediately did not undergo imaging
screening, and follow-up showed no symptoms or abnormal findings. Among 18 neonates admitted to hospital, 17 neonates had pneumonia-like
imaging changes. Five neonates were diagnosed with a COVID-19 infection, including 2 confirmed and 3 suspected. COVID-19, coronavirus
disease 2019.
https://doi.org/10.1371/journal.pmed.1003195.g001
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chest CT images, as there were not enough PCR kits available. Among 29 pregnant COVID-
19-infected women, 14 experienced mild symptoms including fever (8), cough (9), shortness
of breath (3), diarrhea (2), vomiting (1), whereas 15 women had no symptoms. All chest CT
images showed typical signs of COVID-19 pneumonia. In the 14 women with symptoms, 9
were SARS-CoV-2 RNA positive, while in the 15 symptom-free women with abnormal chest
CT images, 6 were SARS-CoV-2 RNA positive. None of the women required mechanical venti-
lation or were admitted to the ICU.
The distribution of the demographic characteristics, antenatal clinical conditions, and labo-
ratory tests of women is shown in Table 1. The pregnancy-related complications, mode of
delivery, postpartum conditions, and laboratory tests of the mothers are shown in Table 2.
Among 29 pregnant women, 11 had complications during pregnancy, including gestational
hypertensive disorder (2), gestational diabetes mellitus (3), gestational anemia (3), premature
rupture of membrane (5), fetal distress (3), intrahepatic cholestasis of pregnancy (1), hepatitis
(1), thrombocytopenia (1), coagulopathy (2), hypothyroidism (1), and hepatitis B virus (HBV)
infection (1). Although the majority of women had a cesarean section (CS) delivery for non-
medical reasons, 2 women elected to have a vaginal delivery, and both their neonates had
radiological changes for pneumonia but without clinical pneumonia. There was only 1 set of
twins in this study, and both neonates had a pneumonia-like lung image.
Five neonates were diagnosed as having COVID-19 infection, and all were female. The clin-
ical features of these neonates and their mothers are presented in Tables 3 and 4. Brief histories
of the 5 COVID-19-infected neonates are detailed in the supporting information (S2 Text).
The date of birth was defined as Day 1. Based on the typical findings in CT images (Fig 2) and
positive SARS-CoV-2 RNA test in throat swab samples, Patient 5 and Patient 9 were diagnosed
as confirmed COVID-19 infection. Although SARS-CoV-2 specific serum IgM and IgG were
positive in Patient 10 and Patient 18, repeated throat swab tests were all negative. Combined
with the radiological features of viral pneumonia, Patient 10 and Patient 18 were diagnosed as
suspected COVID-19 infection. Because of the characteristic COVID-19 pneumonia manifes-
tations of both lungs (ground-glass opacity [GGO] in bilateral peripheral lungs, Fig 2), Patient
12 was also diagnosed as suspected COVID-19 infection.
The characteristics of the 18 hospitalized neonates are shown in Tables 4 and 5, S1 Table,
Fig 2, S1 and S2 Figs. All 18 neonates had a chest X-ray or CT image within 3 days of delivery
with abnormal radiological findings. The typical pneumonia-like findings were found in the 5
neonates with COVID-19 and 12 other neonates (7 female and 5 male), including diffuse or
scattered patchy obscure shadows of unilateral or bilateral lungs, partial GGO, and multifocal
consolidations, mostly in the lower lobes (Fig 2 and S1 Fig). The other male neonate with mild
birth asphyxia showed increased lung markings and was later diagnosed with hypoxic-ische-
mic encephalopathy (HIE) (Patient 11).
All 18 hospitalized neonates were admitted to the NICU for care (Table 5), and laboratory
tests were performed (see S1 Table for age specific results). Three neonates were born with
congenital heart disease (patent ductus arteriosus [PDA] and atrial septal defect [ASD]), and
they all had radiological features for pneumonia. One neonate with COVID-19 developed a
fever (37.5˚C) on her third day of life, and one neonate had an occasional cough. Throat and
anal swab samples of neonates were repeatedly tested to exclude or confirm COVID-19 infec-
tion, and 2 neonates tested positive in the second of 4 tests. After the New Coronavirus Pneu-
monia Prevention and Control Program (seventh edition) published on March 4, 2020 [17],
SARS-CoV-2 specific IgM and IgG were implemented. A total of 4 neonates were tested, of
which 2 were positive.
During specific or symptomatic treatment, all neonates showed improvement on chest X-
ray or CT images (Tables 4 and 5; Fig 2 and S1 Fig). Follow-up chest X-ray films in 3 cases
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Table 1. Demographic characteristics, prepartum conditions and laboratory tests of mothers infected with COVID-19.
All mothers Mothers whose child had
COVID-19




(n = 29) (n = 5) (n = 12) (n = 12)
No. (%) No. (%) No. (%) No. (%)
Age, mean (SD), year 29.59 (3.56) 29.40 (3.65) 29.33 (4.01) 29.92 (3.34)
BMI, mean (SD), kg/m2 24.10 (5.54) 21.94 (6.10) 23.65 (5.43) 25.45 (5.54)
Educational attainment
College or above 17 (58.62) 1 (20.00) 9 (75.00) 7 (58.33)
High school or lower 12 (41.38) 4 (80.00) 3 (25.00) 5 (41.67)
Occupation
Employed but not at a hospital 11 (37.93) 2 (40.00) 6 (50.00) 3 (25.00)
Employed specifically at a
hospital
4 (13.79) 0 (0.00) 2 (16.67) 2 (16.67)
Unemployed 14 (48.28) 3 (60.00) 4 (33.33) 7 (58.33)
Parity
Primiparous 24 (82.76) 5 (100.00) 10 (83.33) 9 (75.00)
Multiparous 5 (17.24) 0 (0.00) 2 (16.67) 3 (25.00)
First signs and symptoms
Fever 8 (27.59) 2 (40.00) 4 (33.33) 2 (16.67)
Cough 9 (31.03) 2 (40.00) 4 (33.33) 3 (25.00)
Shortness of breath 3 (10.34) 1 (20.00) 1 (8.33) 1 (8.33)
Diarrhea 2 (6.90) 0 (0.00) 1 (8.33) 1 (8.33)
Vomiting 1 (3.45) 1 (20.00) 0 (0.00) 0 (0.00)
None 15 (51.72) 2 (40.00) 6 (50.00) 7 (58.33)
Throat swab 13 (44.83) 3 (60.00) 8 (66.67) 2 (16.67)
Chest CT 29 (100.00) 5 (100.00) 12 (100.00) 12 (100.00)
Prepartum laboratory tests
White blood cell count, median
(IQR), ×109/L
8.03 (4.50) 8.03 (1.58) 9.90 (5.89) 7.30 (3.32)
<3.5 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
3.5–9.5 19 (65.52) 4 (80.00) 6 (50.00) 9 (75.00)
>9.5 10 (34.48) 1 (20.00) 6 (50.00) 3 (25.00)
Lymphocyte count, median (IQR),
×109/L
1.19 (0.48) 1.32 (0.41) 1.17 (0.59) 1.22 (0.35)
<1.1 9 (31.03) 2 (40.00) 4 (33.33) 3 (25.00)
1.1–3.2 20 (68.97) 3 (60.00) 8 (66.67) 9 (75.00)
>3.2 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
Lymphocyte percentage, median
(IQR), %
14.25 (6.37) 16.70 (4.80) 13.00 (3.55) 15.05 (6.95)
C-reactive protein, median (IQR),
mg/L










25.00 (20.30) 17.50 (12.68) 14.50 (6.95)









201.00 (21.00) 202.00 (92.00) 178.50 (44.20)
Total protein, median (IQR), g/L 59.60 (6.65) 56.10 (2.70) 62.20 (9.40) 60.80 (5.67)
Albumin, median (IQR), g/L 36.00 (4.65) 36.30 (5.70) 35.20 (4.68) 36.20 (4.40)
(Continued)
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Table 1. (Continued)
All mothers Mothers whose child had
COVID-19




(n = 29) (n = 5) (n = 12) (n = 12)
No. (%) No. (%) No. (%) No. (%)
Uric acid, median (IQR), μmol/L 296.00
(102.50)
276.00 (69.00) 295.00 (119.70) 308.00 (109.20)
Creatinine, median (IQR), μmol/L 44.00 (9.20) 44.80 (11.10) 44.50 (10.23) 43.75 (6.75)
Urea nitrogen, median (IQR),
mmol/L
2.64 (0.65) 2.16 (0.76) 2.42 (0.53) 2.70 (0.17)
Data are presented as the mean (SD), median (IQR), or frequency (proportion). SI conversion factors: To convert aspartate transaminase, alanine aminotransferase,
creatine kinase, and lactate dehydrogenase to μkat/L, multiply values by 0.0167.
BMI, body mass index; COVID-19, coronavirus disease 2019; CT, computed tomography.
https://doi.org/10.1371/journal.pmed.1003195.t001
Table 2. Pregnancy-related complications, postpartum conditions, and laboratory tests of mothers infected with COVID-19.
All
mothers
Mothers whose child had
COVID-19




(n = 29) (n = 5) (n = 12) (n = 12)




2 (6.90) 0 (0.00) 0 (0.00) 2 (16.67)
Gestational diabetes mellitus 3 (10.34) 1 (20.00) 0 (0.00) 2 (16.67)
Gestational anemia 3 (10.34) 2 (40.00) 1 (8.33) 0 (0.00)
Preterm premature rupture of
membranes
5 (17.24) 0 (0.00) 1 (8.33) 4 (33.33)
Fetal distress 3 (10.34) 0 (0.00) 3 (25.00) 0 (0.00)
Postpartum hemorrhage 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00)
Other complications 5 (17.24) 2 (40.00) 1 (8.33) 2 (16.67)
Mode of delivery
Vaginal 2 (6.90) 0 (0.00) 2 (16.67) 0 (0.00)
Cesarean section 27 (93.10) 5 (100.00) 10 (83.33) 12 (100.00)
Number of fetus
Singleton 28 (96.55) 5 (100.00) 11 (91.67) 12 (100.00)
Twin 1 (3.45) 0 (0.00) 1 (8.33) 0 (0.00)
Gestational age at delivery, weeks
35–36 3 (10.34) 0 (0.00) 2 (16.67) 1 (8.33)
37–38 14 (48.28) 3 (60.00) 7 (58.33) 4 (33.33)
39–41 12 (41.38) 2 (40.00) 3 (25.00) 7 (58.33)
White blood cell count, median
(IQR), ×109/L
8.68 (3.32) 7.63 (3.35) 8.47 (4.96) 9.14 (2.28)
Lymphocyte count, median
(IQR), ×109/L










52.00 (78.83) 16.00 (32.00) 24.70 (28.99)
Data are presented as the median (IQR) or frequency (proportion).
COVID-19, coronavirus disease 2019.
https://doi.org/10.1371/journal.pmed.1003195.t002
PLOS MEDICINE Neonates born to COVID-19 mothers
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003195 July 28, 2020 8 / 19
(Patients 9, 10, 18) were performed showing increased lung markings and/or scattered obscure
shadows. Before discharge, chest X-ray films in 4 cases (Patients 5, 9, 10, 12) indicated that pul-
monary lesions had been completely or partially diminished, whereas the chest CT image in 1
neonate (Patient 18) had increased density in previously existing pulmonary lesions with inter-
lobular septal thickening.
Table 3. Clinical features of mothers whose neonates was infected with COVID-19.
Patient 5 9 10 12 18
Symptoms Cough No No Fever, cough, vomiting Fever, stuffy nose, shortness of
breath
Chest CT Patchy GGO in right lung,
especially in right lower lobe
Bilateral
focal GGO
Left lung infectious lesions,
bilateral pleural thickening, little
pleural effusion
Bilateral multiple GGO Bilateral scattered GGO
Throat swab (–) (–) (+) (+) (+) (+)
SARS-CoV-2 IgM,
AU/mL
NA NA NA NA 279.72, Day -1; 112.66, Day 8
SARS-CoV-2 IgG,
AU/mL
NA NA NA NA 107.89, Day -1; 116.30, Day 8
White blood cell
count, ×109/L
8.19 13.7 4.69 6.61 8.03
Lymphocyte count,
×109/L
1.49 1.32 0.78 1.58 1.08
Lymphocyte
percentage, %
18.2 9.6 16.7 23.9 13.4
C-reactive protein,
mg/L
20.4 16.9 NA 7 57
Aspartate
transaminase, U/L
16 10 15.5 56 40
Alanine
aminotransferase, U/L
25 14 17.7 54.7 38
Creatine kinase, U/L 28 56 35 23 17
Lactate
dehydrogenase, U/L
201 216 117 195 222
Total protein, g/L 56.9 62.4 56.1 50.8 54.2
Albumin, g/L 36.3 38.8 31.5 26.5 37.2
Uric acid, μmol/L 339 456 276 270 259
Creatinine, μmol/L 51 45 44.8 33.9 28
Urea nitrogen,
mmol/L
NA NA 1.4 2.91 NA
Treatment Oseltamivir,
Methylprednisolone, Peramivir







No GDM ICP, anemia, HBV infection Anemia Thrombocytopenia
Mode of delivery CS CS CS CS CS
COVID-19 diagnosis Clinical diagnosed Clinical
diagnosed
Confirmed Confirmed Confirmed
SI conversion factors: To convert aspartate transaminase, alanine aminotransferase, creatine kinase, and lactate dehydrogenase to μkat/L, multiply values by 0.0167.
COVID-19, coronavirus disease 2019; CS, cesarean section; CT, computed tomography. GDM, gestational diabetes mellitus; GGO, ground-glass opacity; HBV, hepatitis
B virus; ICP, intrahepatic cholestasis of pregnancy; IgG, immunoglobulin G; IgM, immunoglobulin M; NA, not available; SARS-CoV-2, severe acute respiratory
syndrome coronavirus 2.
https://doi.org/10.1371/journal.pmed.1003195.t003
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The average NICU stay was 13 days, but 3 neonates with abnormal radiological findings
without COVID-19 infection had neonatal necrotizing enterocolitis (NEC) and were therefore
admitted longer. These neonates (Patient 2, 14, 15) developed NEC after birth at 37+6, 40+1,
37+2 weeks’ gestation, respectively (Table 5). The first symptoms included bloody stools
(Patient 2 and Patient 14, both at Day 4), repeated vomiting and bloating (Patient 15 at Day 2).
Further, abdominal X-rays showed abnormalities including intermediate abdominal pneuma-
tosis, and indistinct intestinal space (S2 Fig).
Discussion
Main findings
In this study, among 29 women with confirmed or clinical diagnosed COVID-19 infection, 5
neonates were diagnosed with a COVID-19 infection (2 confirmed and 3 suspected). None of
these 5 neonates had contact with infected patients, except for their mothers during delivery,
which suggests vertical and intrapartum transmission.
Table 4. Clinical features of 5 neonates with COVID-19.
Patient 5 9 10 12 18
Days from mother diagnosed,
days
0 0 0 14 10
Sex Female Female Female Female Female
Gestational age, weeks 40+4 39+1 38+3 37+1 37+6
Birthweight, g 3,360 3,570 2,760 2,940 3,120
AGA AGA AGA AGA AGA AGA
Apgar score at 1 minute 9 9 10 10 9
Apgar score at 5 minutes 10 10 10 10 10
Congenital anomaly No No No ASD No
Symptoms No 37.5˚C, Day 3 No No No
Throat swab (–) (+) (–) (–) (+?) (–) (+) (–) (–) (–) (–) (–) (–) (–) (–) (–) (–) (–) (–) (–)
Anal swab (–) (–) (–) (–) (–)
Chest X-ray or CT after birth,
Fig 2
GGO GGO GGO GGO GGO
White blood cell count,
×109/L
19.23 14.27 16.59 18.79 19.29
Lymphocyte count, ×109/L 2.61 2.19 2.45 2.95 4.3
Lymphocyte percentage, % 13.6 15.3 14.8 15.7 22.3
C-reactive protein, mg/L <0.75 11.4 <0.75 1.09 <0.79
Procalcitonin, ng/mL (–) 2.95 NA NA NA
SARS-CoV-2 IgM, AU/mL NA 0.46, Day 26 10.65, Day 28 NA 45.83, Day 1; 11.75, Day 15








Interferon inhalation Interferon inhalation
NICU stay, days 14 16 29 10 23
Hospitalization stay, days 15 16 29 16 23










COVID-19 diagnosis Confirmed Confirmed Suspected Suspected Suspected
AGA, appropriate for gestational age; ASD, atrial septal defect; COVID-19, coronavirus disease 2019; CT, computed tomography; GGO, ground-glass opacity; IgG,
immunoglobulin G; IgM, immunoglobulin M; NA, not available; NICU, neonatal intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
https://doi.org/10.1371/journal.pmed.1003195.t004
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Fig 2. Chest X-ray or CT (transverse plane) images of 5 neonates diagnosed with COVID-19 infection (2 confirmed, 3
suspected) after birth, in the treatment, and before discharge. (A-B, Patient 5) Chest CT images (A) obtained after birth
showed peripheral GGOs in the posterior basal segment of left lung lower lobe. Chest X-ray film (B) before discharge showed
no abnormal findings. (C-E, Patient 9) Chest CT images (C) showed diffuse GGO with multifocal consolidations in the
peripheral regions of bilateral lungs. Chest X-ray film (D) in treatment showed patchy obscure shadows in bilateral lung lower
fields. Chest X-ray film (E) before discharge showed complete disappearance of pneumonia. (F-H, Patient 10) Chest CT
images (F) obtained after birth showed patchy GGO in the posterior basal segment of right lower lobe and large GGO in the
posterior basal segment of left lower lobe. Chest X-ray film (G) in treatment showed significant release of pneumonia. Chest
X-ray film (H) before discharge showed nothing abnormal findings except mild increased lung markings. (I-J, Patient 12)
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Results in context
Several case series have been reported focusing on the impact of COVID-19 on pregnant
women and neonates [6–12]. Chen and colleagues [6] first evaluated the clinical characteristics
of COVID-19 infection in 9 mother–neonate pairs. Amniotic fluid, cord blood, neonatal
throat swab, and breastmilk samples were tested from 6 patients for SARS-CoV-2, and all
were negative. In these case series or case reports, the majority COVID-19-infected pregnant
women had mild symptoms and were delivered by CS. Further, all women had lung radiologi-
cal changes, which is consistent with our results. Although in the study by Zhu and colleagues,
10 neonates experienced several clinical problems including premature labor, shortness of
breath, thrombocytopenia, and even death [9]; in other reports, positive neonatal outcomes
were minimal. Only 2 cases of confirmed neonatal COVID-19 infection have been reported
[24]. One neonate was diagnosed at 17 days postdelivery after close contact with a COVID-
19-infected mother and babysitter [25]. The other neonate was found to be infected 36 hours
after a CS delivery after negative cord blood, amniotic fluid, and placenta SARS-CoV-2 RNA
results [26].
In this present study, all neonates with COVID-19 infection were born via CS where both
general hospitals had only 1 negative-pressure operating room. When the neonates were born
through CS, they stayed unprotected in the operating room for about 30 minutes for observa-
tion before they were transferred to isolated neonatal wards. Although a guideline released by
the Hubei government required immediate isolation of neonates from infected mothers [27],
the 30 minutes’ observation had not been noticed by obstetricians. The contaminated air in
the operation room might be the source of the viral transmission, although other transmission
routes cannot be excluded.
Strengths and limitations
This is the first study to our knowledge to integrate the complete data of mothers and neonates
to explore the association between maternal COVID-19 infection and neonatal COVID-19
infection or other health conditions. All women with confirmed or clinical diagnosed
COVID-19 infections who gave birth at 2 of the 5 designated general hospitals between Janu-
ary 30 to March 10, 2020 during the most severe time of the epidemic in China were included
in this study. The detailed clinical course of each hospitalized neonates was recorded and the
condition of the nonhospitalized neonates was monitored by telephone interview, thus provid-
ing reliable follow-up data, which have eliminated the recall bias often found in retrospective
studies. However, in the early stage of the outbreak, there was a shortage of COVID-19 test
kits. As such, most neonates were only tested twice with throat and anal swabs. Only 4 neo-
nates were tested for SARS-CoV-2 specific IgM and IgG. Ai and colleagues [28] reported chest
CT had higher sensitivity in diagnosing a COVID-19 infection in comparison to qRT-PCR
tests from swab samples in China. Although more than half of the pregnant women in this
study were clinically diagnosed based on chest CT images due to the lack of PCR kits, we
believe the diagnosis was accurate. Another limitation is the lack of tracheal aspirate to identify
specific pathogens from the first 12 neonates with radiological features for pneumonia. This
Chest CT images (I) obtained after birth showed peripheral focal consolidations in the posterior basal segments of bilateral
lower lobes and multiple patchy GGO bilaterally. Chest X-ray film (J) showed partial absorption of pneumonia. (K-M, Patient
18) Chest CT images (K) obtained after birth showed reduced latency with GGO in bilateral lower lobes. Chest X-ray film (L)
in treatment showed increased bilateral lung markings. Chest X-ray film (M) before discharge showed increased densities of
previous existing pulmonary lesions with interlobular septal thickening. All images have been de-identified to protect patient
privacy. COVID-19, coronavirus disease 2019; CT, computed tomography; GGO, ground-glass opacity.
https://doi.org/10.1371/journal.pmed.1003195.g002
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led to the uncertain etiology of the identified pneumonia. Because we found only 5 neonates
with (suspected) COVID-19 infection, comparison between groups had limited statistical
power.
Research implications
Our findings suggest maternal CRP levels may be associated with neonatal lung radiological
changes, as antenatal CRP levels were higher in mothers of neonates who had abnormal radio-
logical findings (with COVID-19 or without). CRP is the most commonly researched acute-
phase reactant in infection and noninfectious inflammation. There is some evidence to suggest
antenatal CRP levels are associated with pregnancy-related complications [29], mental disor-
ders in offspring [30], infant birthweight [31], and neonatal CRP levels [32]. Although CRP
cannot be transmitted to the fetus through the maternal–fetal interface, maternal inflamma-
tion can affect the fetal immune state including immune cells, cytokines, and chemokines [33].
In the 5 COVID-19-infected neonates in our study (Table 4), we found their clinical mani-
festations were very different from those of infected adults and even children [19]. Neonates
had almost no symptoms, and it was difficult to judge the changes in white blood cells and
lymphocytes because of the differing number of days since birth. In terms of the SARS-CoV-2
RNA tests in throat and anal swab samples, there may have been sampling errors and false neg-
ative or false positive results. As for the detection of the SARS-CoV-2 specific IgM and IgG,
only 4 cases were tested in this study due to late arrival of the testing platform, which may
become a powerful method for identifying the infections in the future. When comparing all
the various diagnostic examinations, the chest CT images appear to be the most important for
a diagnosis and prognosis of COVID-19 among neonates. The typical radiographic findings of
COVID-19 pneumonia in those 5 infants were predominately manifested as focal or diffuse
GGOs located in the peripheral regions, which were distinguishable from bacterial infection
but nonspecific from other virus pneumonia, such as influenza A. After treatment, all neonates
showed improvement on chest X-ray or CT images. However, in 1 neonate (Patient 18), we
found the densities of previous existing lung lesions increased with interlobular septal thicken-
ing, suggested that interstitial fibrosis had developed and may influence pulmonary function
in the future. As previously reported [34], CT scan is more sensitive than X-ray film in detect-
ing pulmonary lesions which are usually overlapped by the shadow of the heart or hidden
behind posterior region of the diaphragms. Considering the safety of ionizing and the need of
avoid wasting a medical resource, it is urgent to develop an effective standard to screen infants
and children for COVID-19.
Notably, although 12 of the 13 other hospitalized neonates presented radiological features
for pneumonia through X-ray or CT, only 1 neonate had an occasional cough, and none of
them had any of the usual symptoms associated with a SARS-CoV-2 infection. It seems that
neonates born to mothers with COVID-19 had a significantly increased risk for pneumonia-
like damage within 6 days of birth. Generally, the incidence rate of neonatal pneumonia is
<1% among full-term infants and approximately 10% in preterm infants [35,36]. However,
the neonates in this study had no specific symptoms of pneumonia, so no microbiological test
had been implemented except for SARS-CoV-2. The increased radiological features for pneu-
monia may be due to false negative of SARS-CoV-2 PCR test, which has a 30% false negative
rate [37]. For example, Patient 12 had a typical CT feature for COVID-19 infection, but her
throat and anal swabs were all negative. As such, it is possible that some of these 12 neonates
had a potential SARS-CoV-2 infection and that early tracheal aspirate should be obtained for
specific pathogen identification. Further, inhalation of amniotic fluid and neonatal wet lung
syndrome may also cause abnormal radiological findings. Following treatment, all the lesions
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shown in S1 Fig resolved, but it is unknown if any long-term effects will develop and warrants
investigation.
For SARS-CoV-2 specific serum IgM and IgG, 2 neonates were positive (Patient 10 and 18)
raising the concern of intrauterine transmission. Currently, SARS-CoV-2 is thought to pri-
marily exist in the respiratory tract and to a lesser extent in the digestive system. Like other
respiratory viruses, the positive rate of nucleic acid testing in blood is not high. The vertical
transmission from mother-to-fetus via placenta usually requires a high replication level of
virus in the blood. This may be the reason why no SARS-CoV-2 was found in the cord blood,
amniotic fluid, or placenta as they were in previous studies [6,38]. When the SARS-CoV-2 spe-
cific IgM and IgG test in serum was proposed, neonates who had not been discharged were
tested. IgM is the earliest synthesized and secreted antibody during human development.
The fetus at the late stage of development begins to synthesize IgM, which is too large to be
passed through the placenta and into the fetus. The rise of IgM is generally considered to be
an indicator of intrauterine or perinatal infection. On the other hand, IgG appears to be pas-
sively transported from the mother to the fetus because it can pass through the placenta and
can be synthesized by the infant after 3 months of age [39]. It is unfortunate both cases had no
retained cord blood, placenta, or amniotic fluid samples so that we could test for the antibod-
ies. Additional research is needed to further clarify vertical transmission.
In addition, 3 neonates developed NEC despite the lack of prematurity. Similar findings
were found among the 5 infants born to infected women during the severe acute respiratory
syndrome (SARS) outbreak [40]. One of the 5 infants born to SARS-infected women devel-
oped neonatal respiratory distress syndrome (NRDS) and jejunal perforation, and another
developed NEC with ileal perforation shortly after birth. These 2 cases included extremely pre-
mature infants in which one was born at 26 weeks’ gestation, and the other was born at 28
weeks. The occurrence of NEC in this study is concerning and warrants further investigation.
Conclusions
Neonates born to COVID-19-infected women had an increased risk of COVID-19 and radio-
logical features for pneumonia. Intrapartum and postpartum exposure to their mother may
have played a role and intrauterine transmission should not be dismissed. Serum test of
SARS-CoV-2 specific IgM and IgG is a valuable test to compensate for a false PCR result. The
increased occurrence of necrotizing enterocolitis among neonates born to COVID-19-infected
women warrants further investigation.
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S1 Fig. Chest X-ray or CT (transverse plane) images of 13 neonates with radiological
change in chest but who were not diagnosed with COVID-19. Left panel of each case was the
chest X-ray or CT performed after birth (within 3 days, mostly within 24 hours). Except one
showing increased bilateral lung markings (H, Patient 11), the other 12 showed the typical
manifestations of pneumonia. The main findings was diffuse or scattered patchy obscure shad-
ows of unilateral or bilateral lungs, 5 cases with partial ground-glass opacities (G, I, J, K, M,
Patient 8, 13, 14, 15, 17), 5 cases with peripheral focal consolidations (E, I, K, L, M, Patient 6,
13, 15, 16, 17), and one case with paramediastinal emphysema (E, Patient 6). Right panel of
each case was the chest X-ray performed before discharge (Patient 11 was performed after dis-
charge), of which 12 neonates with pneumonia-like radiological changes showed absorption
of lesions. Four cases showed slightly increasing lung markings (B, C, D, F, Patient 2, 3, 4, 7).
Only one case showed scattered patchy blurry shadows (K, Patient 15). The other one still
showed increased bilateral lung markings (H, Patient 11). All images have been de-identified
to protect patient privacy. COVID-19, coronavirus disease 2019; CT, computed tomography.
(TIF)
S2 Fig. Abdominal X-ray images of 3 neonates with necrotizing enterocolitis. (A, Patient 2)
Abdominal X-ray images at Day 5 showed intermediate abdominal pneumatosis, indistinct
intestinal space between bowels in the middle and lower abdomen, and the presence of “bubble
sign”. (B, Patient 14) Abdominal X-ray images at Day 5 showed abdominal pneumatosis; indis-
tinct intestinal space between bowels in the right lower abdomen, and slightly linear and bub-
ble-like radiolucencies. (C, Patient 15) Abdominal X-ray images at Day 20 showed mild
abdominal pneumatosis, which was mainly located in the colon, and slightly indistinct intesti-
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